Females experience comparable MACE rates to males despite lower absolute plaque volumes, according to a PROMISE trial analysis of nearly 4,300 stable chest pain patients published in Circulation: Cardiovascular Imaging. Cardiovascular risk in females accelerated at a total plaque burden of ~20%, versus ~28% in males, suggesting uniform plaque thresholds systematically underestimate risk in women.
🔬 Clinical Considerations
- Smaller coronary artery diameter in females means lower absolute plaque volume can reflect equivalent relative disease burden, explaining similar MACE rates across sexes
- Risk rose more steeply at lower plaque levels in females vs a gradual increase in males, a pattern that persisted after adjusting for traditional risk factors and high-risk plaque findings
- No sex-specific plaque burden thresholds currently exist in routine practice; researchers caution against implementing cutoffs before further validation
- Females have been historically undertreated in cardiovascular care, making this a high-stakes gap in current risk stratification tools
⚡ Practice Applications
- Avoid interpreting low absolute plaque volume as low risk in female patients
- Prioritize plaque burden (vessel size-adjusted) over total plaque volume when assessing female cardiovascular risk
- Integrate imaging findings with full clinical risk factor profiles before classifying female patients as low risk
- Follow developing literature on sex-specific and age-specific plaque burden thresholds for future guideline updates
More on Coronary Artery Disease (CAD)
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS